KRD: Device, Vascular, For Promoting Embolization
What it covers
A vascular embolization device is an intravascular implant intended to control hemorrhaging due to aneurysms, certain types of tumors (e.g., nephroma, hepatoma, uterine fibroids), and arteriovenous malformations. This does not include cyanoacrylates and other embolic agents, which act by polymerization or precipitation. Embolization devices used in neurovascular applications are also not included in this classification, see § 882.5950 of this chapter.
The identification in 21 CFR 870.3300, vascular embolization device. FDA gives KRD no definition of its own, so the regulation’s describes it.
FDA flags KRD devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262798 | LOBO Vascular Occlusion System | Okami Medical, Inc. | Oct 6, 2026 | Traditional |
| K252812 | UniPearls® Embolic Microspheres | Suzhou Haowei Medical Technology Co., Ltd. | Jul 31, 2026 | Traditional |
| K261488 | OBSIDIO Conformable Embolic | Boston Scientific Corporation | Jul 24, 2026 | Traditional |
| K261866 | Concerto Versa Detachable Coil | Medtronic, Inc. | Jun 24, 2026 | Special |
| K260635 | HARBOR Occlusion Device | Nuvascular, Inc. | Jun 12, 2026 | Traditional |
| K260508 | LOBO Vascular Occlusion System | Okami Medical, Inc. | Apr 10, 2026 | Traditional |
| K253511 | Concerto Versa Detachable Coil | Medtronic, Inc. | Jan 14, 2026 | Traditional |
| K253677 | Tembo Embolic System | Instylla, Inc. | Dec 15, 2025 | Special |
| K253376 | OBSIDIO Conformable Embolic (M0013972101010) | Boston Scientific Corporation | Oct 30, 2025 | Special |
| K250209 | Polyvinyl Alcohol Embolic Microspheres | Canyon Medical, Inc. | Sep 23, 2025 | Traditional |
Clearances by year
99 KRD 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 7 | 70 |
| 2025 | 9 | 60 |
| 2024 | 6 | 70 |
| 2023 | 2 | 137 |
| 2022 | 8 | 175 |
| 2021 | 3 | 134 |
| 2020 | 4 | 137 |
| 2019 | 6 | 178 |
| 2018 | 4 | 62 |
| 2017 | 4 | 89 |
| 2016 | 4 | 164 |
| 2015 | 11 | 130 |
| 2014 | 7 | 134 |
| 2013 | 11 | 33 |
| 2012 | 8 | 30 |
| 2011 | 5 | 36 |
Who submits
40 applicants cleared a KRD device since 2011. 80% of the clearances went to applicants in United States, then France (9%), China (5%) and United Kingdom (3%). By type: Traditional 67%, Special 32% and Abbreviated 1%.
| Applicant | Clearances since 2011 |
|---|---|
| MicroVention, Inc. | 14 |
| Biosphere Medical, S.A. | 9 |
| Boston Scientific Corporation | 6 |
| Cook Incorporated | 6 |
| Boston Scientific Corp | 5 |
| Vascular Solutions, Inc. | 5 |
| Reverse Medical Corporation | 4 |
| Artventive Medical Group, Inc. | 3 |
How FDA classifies it
Class II (special controls.) The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.” For availability of this guidance document, see § 870.1(e).
From 21 CFR 870.3300. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.3300 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KRD clearances declared.
Ask about KRD
Questions about KRD
What is FDA product code KRD?
Product code KRD, “Device, Vascular, For Promoting Embolization” in FDA's classification database, is a Class II device type under 21 CFR 870.3300 (vascular embolization device), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 133 clearances under KRD, 99 of them since 2011.
How many 510(k) clearances are there under KRD?
FDA’s 510(k) database listed 133 clearances under KRD as of Oct 29, 2026, 99 of them decided since 2011; the most recent decision was Oct 6, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a KRD 510(k)?
For the 17 KRD clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 70 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most KRD clearances?
Since 2011: MicroVention, Inc. (14), Biosphere Medical, S.A. (9), Boston Scientific Corporation (6), Cook Incorporated (6) and Boston Scientific Corp (5). 40 applicants have cleared a KRD device in that time.